TELA Bio, Inc. TELA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.49% | -8.96% | 1.81% | 17.06% | 21.25% |
| Total Depreciation and Amortization | -1.48% | -1.12% | -15.41% | -5.70% | 8.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.90% | 10.53% | 13.63% | 11.22% | -11.70% |
| Change in Net Operating Assets | 16.08% | -108.46% | 208.63% | 176.53% | 307.78% |
| Cash from Operations | -18.67% | -14.86% | 35.33% | 36.34% | 26.10% |
| Capital Expenditure | 48.25% | -271.88% | 65.53% | -72.95% | 61.87% |
| Sale of Property, Plant, and Equipment | -6.29% | 81.76% | 282.43% | -- | -13.11% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 17.16% | 37.68% | 201.05% | 355.74% | 204.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -54.10% | -72.45% | -61.54% | -100.00% |
| Repurchase of Common Stock | -400.00% | 55.37% | 63.64% | -10.53% | 72.73% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -400.00% | -156.90% | -39.77% | -75.51% | 40.00% |
| Foreign Exchange rate Adjustments | 93.42% | 80.60% | -119.23% | 155.32% | -1,166.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.69% | -14.91% | -40.25% | 42.59% | 26.21% |